Kissei Pharmaceutical Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1946-08-09
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.kissei.co.jp
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT01692145
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01629420
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)
- First Posted Date
- 2012-05-16
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT01600001
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents
Phase 1
Completed
- Conditions
- Extravasations of Anthracycline Anti-cancer Agents
- Interventions
- First Posted Date
- 2012-05-10
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 2
- Registration Number
- NCT01596088
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Dose-finding Study of Silodosin in Patients With Urinary Calculi
- First Posted Date
- 2012-02-27
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT01539265
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT01533532
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia
Phase 2
Completed
- Conditions
- Chronic Kidney Disease Requiring Hemodialysis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 183
- Registration Number
- NCT01521494
- Locations
- 🇯🇵
Japan, Multiple Locations, Japan
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
- First Posted Date
- 2011-09-02
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT01427816
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
- First Posted Date
- 2011-07-18
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01395940
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT01384435
- Locations
- 🇯🇵
Japan, Tokyo and Other Japanese City, Japan
© Copyright 2025. All Rights Reserved by MedPath